Chuck Royce's XERS Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 461,153 shares of Xeris Biopharma Holdings, Inc. (XERS) worth $3.65 M, representing 0.03% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in XERS, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 205,066 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Xeris Biopharma Holdings (XERS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xeris Biopharma Holdings (XERS) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +205,066 | Add 80.08% | 461,153 | $7.92 |
| Q1 2026 | +256,087 | New Buy | 256,087 | $5.80 |
Chuck Royce's Xeris Biopharma Holdings Investment FAQs
Chuck Royce first purchased Xeris Biopharma Holdings, Inc. (XERS) in Q1 2026, acquiring 256,087 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Xeris Biopharma Holdings, Inc. (XERS) for 2 quarters since Q1 2026.
Chuck Royce's largest addition to Xeris Biopharma Holdings, Inc. (XERS) was in Q1 2026, adding 256,087 shares worth $1.49 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 461,153 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $3.65 M.
As of the Q2 2026 filing, Xeris Biopharma Holdings, Inc. (XERS) represents approximately 0.03% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Xeris Biopharma Holdings, Inc. (XERS) was 461,153 shares, as reported at the end of Q2 2026.